Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 10;95(1):e28364. doi: 10.1002/jmv.28364

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Profiling of plasma monocyte/macrophage‐related soluble factors from individuals with ongoing PASC, without PASC, and without SARS‐COV‐2 infection. Mean plasma cytokine/chemokine/soluble factor levels of individuals with no prior COVID‐19 (n = 28), individuals who never reported PASC postinfection (n = 62), or with ongoing PASC (n = 91). Error bars indicate ±SD. Statistical analysis: Welch's analysis of variance for comparison of all three groups and two‐sided Welch corrected t‐test for comparison of the no prior COVID‐19 versus never PASC, no prior COVID‐19 versus ongoing PASC, and never PASC versus ongoing PASC groups. PASC, post‐acute sequelae of COVID.